Bio-UV Group (ALTUV.PA) Stock Price

Bio-UV Group Price

Euronext·CLOSED
1.30EUR+0.01 (+1.16 %)
Market closed

Revenue has compounded at 16.6% per year over the past 9 years to 35.25 M EUR. Earnings per share have declined at 9.9% per year over the last 9 years. Bio-UV Group's net margin stands at 2.4%, broadly stable from 2.1% several years earlier. Bio-UV Group currently offers a dividend yield of about 1.62%. The payout ratio is around 168% of earnings. Analysts set a median price target of 2.55 EUR, implying 96.2% above the current price. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus. The stock trades about 7% above its 52-week low.

Bio-UV Group stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Bio-UV Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Bio-UV Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Bio-UV Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Bio-UV Group Stock Price History
DateBio-UV Group Price
8/4/20261.30 EUR
7/31/20261.28 EUR
7/30/20261.28 EUR
7/29/20261.27 EUR
7/28/20261.29 EUR
7/27/20261.29 EUR
7/24/20261.31 EUR
7/23/20261.35 EUR
7/22/20261.35 EUR
7/21/20261.35 EUR
7/20/20261.34 EUR
7/17/20261.35 EUR
7/16/20261.35 EUR
7/15/20261.34 EUR
7/14/20261.36 EUR
7/13/20261.36 EUR
7/10/20261.35 EUR
7/9/20261.34 EUR
7/8/20261.35 EUR
7/7/20261.35 EUR
7/6/20261.35 EUR
7/3/20261.36 EUR
7/2/20261.33 EUR
7/1/20261.34 EUR
6/30/20261.29 EUR
6/29/20261.35 EUR
6/26/20261.34 EUR
6/25/20261.34 EUR
6/24/20261.38 EUR
6/23/20261.35 EUR
6/22/20261.36 EUR
6/19/20261.34 EUR
6/18/20261.36 EUR
6/17/20261.37 EUR
6/16/20261.37 EUR
6/15/20261.37 EUR
6/12/20261.37 EUR
6/11/20261.37 EUR
6/10/20261.37 EUR
6/9/20261.39 EUR
6/8/20261.40 EUR
6/5/20261.40 EUR
6/4/20261.40 EUR
6/3/20261.40 EUR
6/2/20261.41 EUR
6/1/20261.37 EUR
5/29/20261.40 EUR
5/28/20261.40 EUR
5/27/20261.42 EUR
5/26/20261.39 EUR
5/25/20261.40 EUR
5/22/20261.39 EUR
5/21/20261.38 EUR
5/20/20261.37 EUR
5/19/20261.39 EUR
5/18/20261.39 EUR
5/15/20261.41 EUR
5/14/20261.31 EUR
5/13/20261.33 EUR
5/12/20261.40 EUR
5/11/20261.40 EUR
5/8/20261.35 EUR
5/7/20261.34 EUR
5/6/20261.33 EUR
5/5/20261.35 EUR
5/4/20261.35 EUR
4/30/20261.36 EUR
4/29/20261.37 EUR
4/28/20261.36 EUR
4/27/20261.37 EUR
4/24/20261.36 EUR
4/23/20261.32 EUR
4/22/20261.35 EUR
4/21/20261.35 EUR
4/20/20261.35 EUR
4/17/20261.36 EUR
4/16/20261.35 EUR
4/15/20261.32 EUR
4/14/20261.36 EUR
4/13/20261.36 EUR
4/10/20261.37 EUR
4/9/20261.37 EUR
4/8/20261.35 EUR
4/7/20261.30 EUR
4/2/20261.22 EUR
4/1/20261.22 EUR
3/31/20261.25 EUR
3/30/20261.29 EUR
3/27/20261.30 EUR
3/26/20261.30 EUR
3/25/20261.31 EUR
3/24/20261.39 EUR
3/23/20261.39 EUR
3/20/20261.51 EUR
3/19/20261.52 EUR
3/18/20261.51 EUR
3/17/20261.50 EUR
3/16/20261.50 EUR
3/13/20261.54 EUR
3/12/20261.39 EUR
3/11/20261.35 EUR
3/10/20261.31 EUR
3/9/20261.30 EUR
3/6/20261.31 EUR
3/5/20261.31 EUR
3/4/20261.29 EUR
3/3/20261.29 EUR
3/2/20261.30 EUR
2/27/20261.30 EUR
2/26/20261.31 EUR
2/25/20261.29 EUR
2/24/20261.28 EUR
2/23/20261.29 EUR
2/20/20261.29 EUR
2/19/20261.28 EUR
2/18/20261.29 EUR
2/17/20261.30 EUR
2/16/20261.31 EUR
2/13/20261.31 EUR
2/12/20261.33 EUR
2/11/20261.33 EUR
2/10/20261.30 EUR
2/9/20261.30 EUR
2/6/20261.32 EUR
2/5/20261.33 EUR
2/4/20261.34 EUR
2/3/20261.35 EUR
2/2/20261.37 EUR
1/30/20261.37 EUR
1/29/20261.37 EUR
1/28/20261.40 EUR
1/27/20261.39 EUR
1/26/20261.38 EUR
1/23/20261.41 EUR
1/22/20261.46 EUR
1/21/20261.47 EUR
1/20/20261.48 EUR
1/19/20261.47 EUR
1/16/20261.49 EUR
1/15/20261.48 EUR
1/14/20261.45 EUR
1/13/20261.44 EUR
1/12/20261.45 EUR
1/9/20261.48 EUR
1/8/20261.50 EUR
1/7/20261.53 EUR
1/6/20261.52 EUR
1/5/20261.53 EUR
1/2/20261.52 EUR
12/31/20251.48 EUR
12/30/20251.47 EUR
12/29/20251.46 EUR
12/24/20251.46 EUR
12/23/20251.49 EUR
12/22/20251.51 EUR
12/19/20251.53 EUR
12/18/20251.54 EUR
12/17/20251.54 EUR
12/16/20251.55 EUR
12/15/20251.53 EUR
12/12/20251.52 EUR
12/11/20251.52 EUR
12/10/20251.50 EUR
12/9/20251.56 EUR
12/8/20251.56 EUR
12/5/20251.59 EUR
12/4/20251.57 EUR
12/3/20251.55 EUR
12/2/20251.56 EUR
12/1/20251.56 EUR
11/28/20251.59 EUR
11/27/20251.57 EUR
11/26/20251.56 EUR
11/25/20251.56 EUR
11/24/20251.57 EUR
11/21/20251.57 EUR
11/20/20251.58 EUR
11/19/20251.57 EUR
11/18/20251.56 EUR
11/17/20251.58 EUR
11/14/20251.58 EUR
11/13/20251.58 EUR
11/12/20251.57 EUR
11/11/20251.58 EUR
11/10/20251.59 EUR
11/7/20251.59 EUR
11/6/20251.64 EUR
11/5/20251.64 EUR
11/4/20251.60 EUR
11/3/20251.59 EUR
10/31/20251.65 EUR
10/30/20251.56 EUR
10/29/20251.60 EUR
10/28/20251.55 EUR
10/27/20251.59 EUR
10/24/20251.61 EUR
10/23/20251.55 EUR
10/22/20251.57 EUR
10/21/20251.58 EUR
10/20/20251.59 EUR
10/17/20251.58 EUR
10/16/20251.58 EUR
10/15/20251.59 EUR
10/14/20251.61 EUR
10/13/20251.61 EUR
10/10/20251.60 EUR
10/9/20251.64 EUR
10/8/20251.64 EUR
10/7/20251.65 EUR
10/6/20251.67 EUR
10/3/20251.69 EUR
10/2/20251.63 EUR
10/1/20251.61 EUR
9/30/20251.61 EUR
9/29/20251.60 EUR
9/26/20251.62 EUR
9/25/20251.62 EUR
9/24/20251.63 EUR
9/23/20251.63 EUR
9/22/20251.67 EUR
9/19/20251.68 EUR
9/18/20251.63 EUR
9/17/20251.61 EUR
9/16/20251.60 EUR
9/15/20251.69 EUR
9/12/20251.68 EUR
9/11/20251.69 EUR
9/10/20251.69 EUR
9/9/20251.70 EUR
9/8/20251.70 EUR
9/5/20251.69 EUR
9/4/20251.69 EUR
9/3/20251.70 EUR
9/2/20251.70 EUR
9/1/20251.71 EUR
8/29/20251.72 EUR
8/28/20251.72 EUR
8/27/20251.73 EUR
8/26/20251.79 EUR
8/25/20251.82 EUR
8/22/20251.71 EUR
8/21/20251.70 EUR
8/20/20251.71 EUR
8/19/20251.72 EUR
8/18/20251.70 EUR
8/15/20251.71 EUR
8/14/20251.73 EUR
8/13/20251.74 EUR
8/12/20251.74 EUR
8/11/20251.74 EUR
8/8/20251.73 EUR
8/7/20251.73 EUR
8/6/20251.73 EUR
Access this data via the Eulerpool API
Get Free API Key

Bio-UV Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
33.09 M EUR
997,635.00 EUR
689,376.00 EUR
Jan 1, 2022
49.82 M EUR
4.13 M EUR
2.42 M EUR
Jan 1, 2023
41.79 M EUR
2.30 M EUR
124,891.00 EUR
Jan 1, 2024
38.62 M EUR
1.06 M EUR
31,361.00 EUR
Jan 1, 2025
35.25 M EUR
1.18 M EUR
836,336.00 EUR
Jan 1, 2026 (e)
38.50 M EUR
875,978.00 EUR
1.05 M EUR
Jan 1, 2027 (e)
40.80 M EUR
928,310.00 EUR
1.05 M EUR
Jan 1, 2028 (e)
43.30 M EUR
985,191.00 EUR
1.36 M EUR

Bio-UV Group Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 5, 2026, 8:47 PM
 
REVENUEM EUR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM EUR
EBITM EUR
EBIT MARGIN%
NET INCOMEM EUR
SHARESM
20162017201820192020202120222023202420252026e2027e2028e
9.0010.0012.0019.0032.0033.0051.0043.0039.0035.0038.0040.0043.00
–11.1120.0058.3368.423.1354.55-15.69-9.30-10.268.575.267.50
33.3340.0033.3331.583.133.037.8458.1461.542.862.862.862.86
3.004.004.006.001.001.004.0025.0024.001.001.091.141.23
––––1.00–4.002.001.001.00–––
––––3.13–7.844.652.562.86–––
1.00–––––2.00–––1.001.001.00
7.807.840.017.988.7410.2012.749.9710.1213.0113.0113.0113.01
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Bio-UV Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Bio-UV Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Bio-UV Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Bio-UV Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Bio-UV Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Bio-UV Group stock margins

The Bio-UV Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bio-UV Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bio-UV Group.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
5.56 %
3.01 %
2.08 %
Jan 1, 2022
9.45 %
8.29 %
4.85 %
Jan 1, 2023
61.20 %
5.50 %
0.30 %
Jan 1, 2024
62.39 %
2.73 %
0.08 %
Jan 1, 2025
5.66 %
3.35 %
2.37 %
Jan 1, 2026 (e)
5.66 %
2.28 %
2.72 %
Jan 1, 2027 (e)
5.66 %
2.28 %
2.57 %
Jan 1, 2028 (e)
5.66 %
2.28 %
3.14 %

Bio-UV Group Stock Revenue, EBIT, Earnings per Share

The Bio-UV Group earnings per share therefore indicates how much revenue Bio-UV Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
3.24 EUR
0.10 EUR
0.07 EUR
Jan 1, 2022
3.91 EUR
0.32 EUR
0.19 EUR
Jan 1, 2023
4.19 EUR
0.23 EUR
0.01 EUR
Jan 1, 2024
3.82 EUR
0.10 EUR
0.00 EUR
Jan 1, 2025
2.71 EUR
0.09 EUR
0.06 EUR
Jan 1, 2026 (e)
3.68 EUR
0.07 EUR
0.10 EUR
Jan 1, 2027 (e)
3.90 EUR
0.07 EUR
0.10 EUR
Jan 1, 2028 (e)
4.14 EUR
0.08 EUR
0.13 EUR

Bio-UV Group business model & stock analysis

The company Bio-UV Group SA is a French company that specializes in the development and production of water treatment systems. The company was founded in 2000 and has since become a leading manufacturer of UV technology for water treatment systems. The history of Bio-UV Group SA was based on the collaboration of three experienced businessmen in the field of UV technology. They recognized the need for sustainable and environmentally friendly water treatment processes and set out to develop an innovative solution that meets today's environmental requirements. Bio-UV Group SA follows a business model based on the development, manufacturing, and installation of UV systems. UV technology is an environmentally friendly and sustainable method of water treatment that does not require the use of chemicals. Bio-UV specializes in three different sectors: marine, swimming pools, and drinking water. The company offers customized solutions for water treatment tailored to specific requirements. In the marine sector, Bio-UV offers UV systems for use in the shipping industry. These systems are used for disinfecting seawater for boats, yachts, cruise ships, or offshore platforms. The systems are used for drinking water or ballast water treatment. In the swimming pool sector, Bio-UV offers UV systems for private and public swimming pools. These systems reduce the use of chlorine and other chemicals and ensure better water quality. The use of UV systems can also prevent unpleasant odors and skin irritations. In the drinking water sector, Bio-UV offers UV systems for the treatment of drinking water. The UV systems eliminate bacteria, viruses, and impurities from drinking water. The systems are used in public buildings, hotels, and hospitals. Bio-UV Group SA offers a variety of products tailored to the specific needs of customers. The products range from small, portable UV systems to large systems for the disinfection of seawater. The products are offered under the brand name "Bio-UV". In recent years, Bio-UV has introduced several innovative products to the market. One of these products is "Bio-SEA", a UV system for ballast water treatment on ships. The system disinfects ballast water to prevent the transmission of pests and diseases through the transport of water from one location to another. In conclusion, Bio-UV Group SA is a leading manufacturer of UV systems for water treatment. The company has developed innovative solutions to meet the demand for environmentally friendly water treatment systems. Through specialization in three different sectors and customized solutions for customers, Bio-UV has earned a good reputation and a leading position in its industry.

Bio-UV Group SWOT Analysis

Strengths

Bio-UV Group SA has various strengths that contribute to its success. The company has a strong portfolio of innovative and technologically advanced products in the field of ultraviolet (UV) water treatment. These products are highly effective in disinfection and purification processes, making them highly sought after in industries such as water treatment, aquaculture, and air purification.

Additionally, Bio-UV Group SA has a strong emphasis on research and development, allowing them to continuously improve their product offerings and stay ahead of the competition. The company also has a well-established global presence, with a strong network of distributors and strategic partnerships in key markets.

Weaknesses

Despite the company's strengths, Bio-UV Group SA also faces certain weaknesses. One of the major weaknesses is its dependence on a few key markets and customers. This can expose the company to significant risks if there is a downturn or disruption in these markets. Additionally, the company may face challenges in terms of scalability and production capacity as the demand for their products increases.

Another weakness is the limited brand awareness of Bio-UV Group SA compared to some well-established competitors in the industry. This may make it difficult for the company to attract new customers and expand its market share.

Opportunities

There are several opportunities for Bio-UV Group SA to capitalize on. The growing global focus on environmental sustainability and water quality presents a significant opportunity for the company. With its UV water treatment solutions, Bio-UV Group SA can effectively address the increasing demand for clean and safe water in various industries.

Furthermore, the company can explore new markets and geographies to diversify its customer base and reduce dependence on specific regions. The increasing regulations and standards for water treatment and disinfection also provide an opportunity for Bio-UV Group SA to expand its market reach and establish itself as a leader in the industry.

Threats

Bio-UV Group SA faces several threats that could impact its business. One of the major threats is intense competition from well-established players in the industry. These competitors may have greater financial resources, brand recognition, and market presence, posing a challenge for Bio-UV Group SA to capture market share.

Additionally, economic uncertainties and market fluctuations can also pose threats to the company's growth and profitability. Changes in regulations and policies related to water treatment and disinfection may also impact the demand for Bio-UV Group SA's products.

Bio-UV Group Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Bio-UV Group historical P/E ratio, EBIT multiple, and P/S ratio

Bio-UV Group annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Bio-UV Group shares outstanding

The number of shares of Bio-UV Group was 13.01 M in 2025. This indicates how many shares Bio-UV Group is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
10.20 M Stocks
Jan 1, 2022
12.74 M Stocks
Jan 1, 2023
9.97 M Stocks
Jan 1, 2024
10.12 M Stocks
Jan 1, 2025
13.01 M Stocks
Jan 1, 2026 (e)
13.01 M Stocks
Jan 1, 2027 (e)
13.01 M Stocks
Jan 1, 2028 (e)
13.01 M Stocks

Bio-UV Group Dividend History

2 years of dividend payments

YearAnnual DividendYoY ChangePayments
20230.02EUR↓ 58.0%1×
20220.05EUR—1×

Bio-UV Group dividend payout ratio

In 2025, Bio-UV Group had a payout ratio of 97.00%. The payout ratio indicates the percentage of the company's profits that Bio-UV Group distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
97.00 %
Jan 1, 2022
26.34 %
Jan 1, 2023
167.66 %
Jan 1, 2024
97.00 %
Jan 1, 2025
97.00 %
Jan 1, 2026 (e)
120.56 %
Jan 1, 2027 (e)
104.85 %
Jan 1, 2028 (e)
107.47 %

Current Bio-UV Group forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
16.67 %
Buy
88.89 % (8)
Hold
11.11 % (1)
Sell
0.00 % (0)
12M Price Target
2.55
Last Price
1.30
Currency
EUR
12M Return Potential
96.15 %
LTM Return
0 %

Bio-UV Group shareholder structure

% Name
5.70294%
Lazard Frères Gestion S.A.S.
Lazard Frères Gestion S.A.S.
0.77556%
Talence Gestion, SAS
Talence Gestion, SAS
0.76451%
Consultinvest Asset Management SGR S.p.A.
Consultinvest Asset Management SGR S.p.A.

Bio-UV Group Beneficial Ownership Filings (SEC 13D/G)

Free Float
82.8%
Float Shares
-
Shares Outstanding
-

Bio-UV Group Executives and Management Board

8 members · avg. age 60 · 25 % women

Management

LM

Mr. Laurent-Emmanuel Migeon (54)

Chairman of the Board, Chief Executive Officer · since 2018

–

Board of Directors

SM

Mr. Simon Marshall

Deputy General Director, Director · since 2020

–
XB

Mr. Xavier Bayle (59)

R&D Director, Director · since 2018

–
TC

Mr. Thierry Carles

Director

–
BG

Mr. Benoit Gillmann (67)

Director · since 2018

–
SB

Ms. Stephanie Le Beuze

Independent Director

–
VQ

Mr. Vincent Quere

Independent Director

–

Bio-UV Group Supply Chain

Bio-UV Group Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
1 companies
#NameTrend
1
TECO 2030
Customer·Machinery·NO
0.40
-0.13
0.15
0.07
0.59
—

Frequently asked questions about Bio-UV Group

The business model of Bio-UV Group SA revolves around providing innovative and sustainable solutions for water treatment and air purification. As a leading company in ultraviolet-C (UV-C) technology, Bio-UV Group SA designs, manufactures, and markets UV-C disinfection systems for various applications. Their advanced and eco-friendly solutions are used in sectors such as residential and commercial pools, aquariums, wastewater treatment plants, and ballast water treatment for ships. With a strong focus on research and development, Bio-UV Group SA continuously aims to enhance their product portfolio and expand their market globally.

Bio-UV Group SA is primarily active in the industries of water treatment, particularly in the field of ultraviolet (UV) water disinfection systems. The company specializes in providing cutting-edge solutions for the treatment of water, ensuring a safe and sustainable environment. Bio-UV Group SA's expertise lies in developing and manufacturing advanced UV-based systems, which find applications across various sectors such as residential, commercial, swimming pools, and aquaculture. Through continuous innovation and a strong commitment to environmental protection, Bio-UV Group SA is a leading player in the global water treatment industry.

The main competitors of Bio-UV Group SA in the market are companies like Trojan Technologies, Halma, Xylem Inc., and Evoqua Water Technologies.

Bio-UV Group SA is a renowned company specializing in ultraviolet light water treatment solutions. Established in 2000, the company has a rich history of innovation, expertise, and commitment to sustainable water treatment technologies. Bio-UV Group SA has consistently delivered advanced and reliable disinfection systems for various applications, including residential, industrial, and commercial sectors. Their cutting-edge products, such as ballast water treatment systems and UV-C LED solutions, have gained recognition worldwide for their effectiveness in eradicating harmful microorganisms. With a strong emphasis on research and development, Bio-UV Group SA continues to be a leading player in the global water treatment industry, providing eco-friendly and efficient solutions for clean and safe water purification.

Bio-UV Group SA, a leading environmental technology company, has achieved several significant milestones. Firstly, they have successfully developed and commercialized innovative ultraviolet light water treatment solutions for global markets. Additionally, Bio-UV Group SA has established a strong presence in the marine industry, with their ultraviolet-based BWTS (Ballast Water Treatment System) being awarded type approval by several authorities. Furthermore, the company has experienced remarkable growth and expansion, both domestically and internationally, fostering strong partnerships and increasing their market share. Through their dedication to cutting-edge technology and commitment to sustainable solutions, Bio-UV Group SA continues to set new milestones in the field of water treatment and environmental preservation.

Bio-UV Group SA is primarily present in several countries and regions. It has a significant presence in France, where the company is headquartered. Additionally, Bio-UV Group SA operates in other European countries, including Spain, Italy, Germany, and the United Kingdom. The company also has a presence in the United States, as well as in Asia, particularly in China. With its global expansion strategy, Bio-UV Group SA aims to serve customers worldwide, ensuring its innovative UV water treatment and disinfection solutions are accessible in various markets and regions.

Bio-UV Group SA represents values and a corporate philosophy that prioritize innovation, sustainability, and excellence. As a leading company in water and air treatment solutions, Bio-UV Group SA is committed to developing cutting-edge technologies that provide efficient and eco-friendly alternatives. With a strong focus on research and development, they continuously strive to deliver high-quality products tailored to meet the needs of their customers. By embracing environmentally friendly practices, Bio-UV Group SA aims to make a positive impact on global health and the environment.

Analysts currently set an average price target of 2.55 EUR for the Bio-UV Group stock (median: 2.55 EUR), implying +96.2 % versus the latest price. The consensus is based on 9 analyst ratings.

Bio-UV Group Analyst Price Targets 2026

9 analysts currently rate the Bio-UV Group stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Bio-UV Group to generate revenue of 38.50 M EUR and earnings per share of 0.08 EUR.

Bio-UV Group Analyst Price Targets 2026

The Bio-UV Group share (ALTUV.PA) is listed on 4 stock exchanges, including: Frankfurt (4Y4.F), München (4Y4.MU), Paris (ALTUV.PA).

The Bio-UV Group SA is a French company that provides solutions for water and air disinfection. The company focuses on providing environmentally friendly and resource-saving technologies. The Bio-UV Group SA operates in two business areas: shipping and water management. In the shipping sector, the Bio-UV Group SA offers systems for disinfecting onboard water, wastewater, and ballast water. These systems are particularly important to prevent the spread of diseases and the introduction of invasive species. Bio-UV's ballast water disinfection systems are approved by the International Maritime Organization (IMO) and the United States Coast Guard (USCG). In the water management sector, the Bio-UV Group SA provides solutions for disinfecting municipal wastewater and drinking water, as well as for process water treatment. The products use UV-C radiation to eliminate viruses, bacteria, and other pollutants. As a result, they are an environmentally friendly alternative to conventional chemical disinfectants. One of the products of the Bio-UV Group SA is the BIO-SCAN, a portable device for water quality analysis. This device measures various parameters such as pH value, dissolved oxygen, and nitrate. Through fast and accurate analysis, contaminations can be detected and remedied early on. The Bio-UV Group SA aims to promote sustainability and improve environmental protection. Its products and technologies offer environmentally friendly alternatives to conventional disinfectants, thereby helping to reduce environmental pollution. In summary, the business model of the Bio-UV Group SA is based on providing environmentally friendly disinfection solutions. The two business areas of the company, shipping and water management, offer various products that use UV-C radiation to eliminate pollutants. The company is focused on sustainability and environmental protection, striving to reduce environmental pollution.

The expected revenue of Bio-UV Group is 38.50 M EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Bio-UV Group is 1.05 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Bio-UV Group is currently 16.16. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Bio-UV Group stock.

The price-to-sales ratio (P/S) of Bio-UV Group is currently 0.44. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Bio-UV Group stock.

The Eulerpool Quality Score for Bio-UV Group is 2/10.

The ISIN of Bio-UV Group is FR0013345493. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Bio-UV Group is A2JQPS. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Bio-UV Group is ALTUV.PA. The ticker symbol is used to trade Bio-UV Group shares on the stock exchange.

The current dividend yield of Bio-UV Group is 1.62 %.

Bio-UV Group paid dividends every year for the past 0 years.

Bio-UV Group is assigned to the 'Industry' sector.

To receive the latest dividend of Bio-UV Group from amounting to 0.02 EUR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Bio-UV Group are distributed in EUR.

All fundamentals and in-depth analysis of Bio-UV Group

Our stock analysis for Bio-UV Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bio-UV Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Bio-UV Group Stock
Bio-UV Group Revenue→
Bio-UV Group Stock
Bio-UV Group Net Income→
Bio-UV Group Stock
Bio-UV Group P/E→
Bio-UV Group Stock
Bio-UV Group P/S→
Bio-UV Group Stock
Bio-UV Group EBIT→
Bio-UV Group Stock
Bio-UV Group Dividend→
Bio-UV Group Stock
Bio-UV Group Directors Dealings→
Bio-UV Group Stock
Bio-UV Group Stocks→
Bio-UV Group Stock
Bio-UV Group Market capitalization→
Bio-UV Group Stock
Bio-UV Group Debt→
Bio-UV Group Stock
Bio-UV Group Liabilities→
Bio-UV Group Stock
Bio-UV Group Equity→
Bio-UV Group Stock
Bio-UV Group AAQS→
Bio-UV Group Stock
Bio-UV Group Employees→
Bio-UV Group Stock
Bio-UV Group ROE→
Bio-UV Group Stock
Bio-UV Group ROA→
Bio-UV Group Stock
Bio-UV Group ROCE→
Bio-UV Group Stock
Bio-UV Group News→
Bio-UV Group Stock
Bio-UV Group Analyst Price Targets→

Industry Stocks

Bion Environmental TechnologiesBio Green Energy Tech PCLBioremBintang Samudera Mandiri Lines Tbk PTBioterBintang Mitra Semestaraya Tbk PTBirchtechBintai Kinden Corporation BhdBird ConstructionBinjiang Service Group CoBirla Precision TechnologiesBinhthuan Agriculture Services JSCAll Stocks A–Z →